Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - Euronext Oslo - NO0010208051 - Common Stock - Currency: NOK

395.85  -0.85 (-0.21%)

Fundamental Rating

4

Taking everything into account, YAR scores 4 out of 10 in our fundamental rating. YAR was compared to 69 industry peers in the Chemicals industry. YAR has an average financial health and profitability rating. YAR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

YAR had positive earnings in the past year.
In the past year YAR had a positive cash flow from operations.
YAR had positive earnings in each of the past 5 years.
In the past 5 years YAR always reported a positive cash flow from operatings.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

YAR has a Return On Assets (1.85%) which is comparable to the rest of the industry.
YAR has a Return On Equity of 3.86%. This is comparable to the rest of the industry: YAR outperforms 56.52% of its industry peers.
With a decent Return On Invested Capital value of 6.87%, YAR is doing good in the industry, outperforming 69.57% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for YAR is above the industry average of 6.66%.
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROIC 6.87%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of YAR (2.05%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of YAR has declined.
Looking at the Operating Margin, with a value of 7.91%, YAR is in the better half of the industry, outperforming 63.77% of the companies in the same industry.
In the last couple of years the Operating Margin of YAR has declined.
YAR's Gross Margin of 27.32% is in line compared to the rest of the industry. YAR outperforms 43.48% of its industry peers.
In the last couple of years the Gross Margin of YAR has remained more or less at the same level.
Industry RankSector Rank
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), YAR is creating some value.
Compared to 1 year ago, YAR has about the same amount of shares outstanding.
YAR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, YAR has a worse debt to assets ratio.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

YAR has an Altman-Z score of 2.78. This is not the best score and indicates that YAR is in the grey zone with still only limited risk for bankruptcy at the moment.
YAR's Altman-Z score of 2.78 is fine compared to the rest of the industry. YAR outperforms 68.12% of its industry peers.
YAR has a debt to FCF ratio of 8.76. This is a slightly negative value and a sign of low solvency as YAR would need 8.76 years to pay back of all of its debts.
YAR has a Debt to FCF ratio of 8.76. This is in the better half of the industry: YAR outperforms 62.32% of its industry peers.
YAR has a Debt/Equity ratio of 0.52. This is a neutral value indicating YAR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, YAR is in line with its industry, outperforming 46.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Altman-Z 2.78
ROIC/WACC0.82
WACC8.39%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.90 indicates that YAR should not have too much problems paying its short term obligations.
YAR has a Current ratio (1.90) which is comparable to the rest of the industry.
A Quick Ratio of 0.96 indicates that YAR may have some problems paying its short term obligations.
The Quick ratio of YAR (0.96) is worse than 60.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.96
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

YAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 175.00%, which is quite impressive.
Measured over the past years, YAR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.01% on average per year.
The Revenue has decreased by -2.88% in the past year.
The Revenue has been growing slightly by 1.52% on average over the past years.
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%

3.2 Future

Based on estimates for the next years, YAR will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.73% on average per year.
The Revenue is expected to grow by 4.81% on average over the next years.
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y4.81%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.73, the valuation of YAR can be described as correct.
Based on the Price/Earnings ratio, YAR is valued a bit cheaper than 72.46% of the companies in the same industry.
YAR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.34.
Based on the Price/Forward Earnings ratio of 12.54, the valuation of YAR can be described as correct.
Based on the Price/Forward Earnings ratio, YAR is valued a bit cheaper than 68.12% of the companies in the same industry.
YAR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 15.73
Fwd PE 12.54
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

82.61% of the companies in the same industry are more expensive than YAR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, YAR is valued a bit cheaper than 71.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.71
EV/EBITDA 6.39
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
YAR's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

YAR has a Yearly Dividend Yield of 1.33%.
YAR's Dividend Yield is comparable with the industry average which is at 3.00.
With a Dividend Yield of 1.33, YAR pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

YAR pays out 41.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of YAR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP41.38%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (6/19/2025, 2:57:59 PM)

395.85

-0.85 (-0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-18 2025-07-18/bmo
Inst Owners42.41%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap100.83B
Analysts57.86
Price Target363.18 (-8.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend4.68
Dividend Growth(5Y)-8.8%
DP41.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.75%
Min EPS beat(2)-47.21%
Max EPS beat(2)37.7%
EPS beat(4)3
Avg EPS beat(4)19.35%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)40.78%
EPS beat(12)6
Avg EPS beat(12)23.78%
EPS beat(16)7
Avg EPS beat(16)11.92%
Revenue beat(2)1
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)0.19%
Revenue beat(4)1
Avg Revenue beat(4)-2.83%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)0.19%
Revenue beat(8)1
Avg Revenue beat(8)-8.1%
Revenue beat(12)2
Avg Revenue beat(12)-4.97%
Revenue beat(16)4
Avg Revenue beat(16)-3.46%
PT rev (1m)0.39%
PT rev (3m)2.53%
EPS NQ rev (1m)14.58%
EPS NQ rev (3m)-8.44%
EPS NY rev (1m)0%
EPS NY rev (3m)4.92%
Revenue NQ rev (1m)-2.6%
Revenue NQ rev (3m)2.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.48%
Valuation
Industry RankSector Rank
PE 15.73
Fwd PE 12.54
P/S 0.72
P/FCF 21.71
P/OCF 6.51
P/B 1.35
P/tB 1.52
EV/EBITDA 6.39
EPS(TTM)25.16
EY6.36%
EPS(NY)31.56
Fwd EY7.97%
FCF(TTM)18.23
FCFY4.61%
OCF(TTM)60.82
OCFY15.36%
SpS553.35
BVpS293.05
TBVpS260.07
PEG (NY)0.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROCE 8.99%
ROIC 6.87%
ROICexc 7.05%
ROICexgc 7.58%
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
FCFM 3.29%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Debt/EBITDA 1.8
Cap/Depr 104.6%
Cap/Sales 7.7%
Interest Coverage 4.23
Cash Conversion 72%
Profit Quality 161.03%
Current Ratio 1.9
Quick Ratio 0.96
Altman-Z 2.78
F-Score6
WACC8.39%
ROIC/WACC0.82
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y4.81%
EBIT growth 1Y140.56%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y12.96%
FCF growth 1Y-69.97%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-39.59%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%